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Radical nephrectomy has traditionally been the stan-
dard treatment for renal cell carcinoma (RCC), while
nephron-sparing surgery is used to treat a tumor in a
solitary kidney or tumors associated with chronic renal
insufficiency. During the past 15 years, many studies
have shown that the cure rates of nephron-sparing
surgery for small lesions are similar to those obtained
with radical surgery [1,2]. Now, the indications for
partial nephrectomy have expanded to include small,
unilateral lesions in patients who have a normal 
contralateral kidney.
Since the first performance of laparoscopic nephrec-
tomy by Clayman et al in 1991 [3], laparoscopic renal
surgery has expanded to include partial nephrectomy,
which has the advantage of requiring minimal inva-
sive surgery, while yielding acceptable morbidity and
complication rates compared with traditional open
surgery [4,5].
However, laparoscopic partial nephrectomy (LPN)
is still a technically demanding procedure, and the lack
of a perfect method for achieving hemostasis remains
a major problem. Moreover, renal vessel occlusion
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The purpose of this study was to describe our initial experience with preoperative tumor emboliza-
tion for laparoscopic partial nephrectomy. Between September 2003 and August 2004, six patients
with solid hypervascular renal tumors were treated with a combination of preoperative tumor
embolization and laparoscopic partial nephrectomy. Ethanol (100%) was used to preoperatively
embolize all major vessels supplying the tumor. The laparoscopic partial nephrectomy procedure
was performed without clamping the renal vessels. The mean tumor size was 2.9 cm (range,
2.0–4.0 cm). Mean estimated blood loss was 177 mL (range, 40–410 mL). Mean laparoscopy time
was 243 minutes (range, 160–290 minutes). Histopathology demonstrated an infected cyst in one
patient and a pT1 renal cell carcinoma in five patients, including a specimen with a positive
tumor margin. After a mean follow-up period of 30 months (range, 25–36 months), neither resid-
ual tumor nor recurrent tumor was identified by imaging studies in any of the six patients. Our
initial experience suggests that preoperative embolization for the treatment of hypervascular
renal tumors might reduce blood loss during subsequent laparoscopic partial nephrectomy, espe-
cially in procedures in which the renal vessels are not clamped. Preoperative tumor embolization
may also help prevent the disastrous effect of incomplete tumor resection. A longer follow-up
will be necessary to confirm efficacy.
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during LPN is also problematic because prolonged arte-
rial clamping can induce warm ischemic change and it
is difficult to achieve hypothermia laparoscopically.
Transarterial embolization (TAE) of renal tumors
was first described in 1973 as a preoperative aid to the
resection of localized renal tumors and a means to pal-
liate the symptoms of metastatic disease [6]. Kalman
and Varenhorst reviewed published series and demon-
strated that preoperative embolization could be used
to reduce the size and vascularity of renal tumors, thus
providing a mechanical advantage for any subsequent
nephrectomy [7]. Herein, we describe our initial expe-
rience with the application of TAE before laparoscopic
partial nephrectomy, which was performed without
clamping of renal vessels.
MATERIALS AND METHODS
Between September 2003 and August 2004, six patients
with a single localized exophytic or partially endo-
phytic renal tumor underwent laparoscopic partial
nephrectomy at our institution. All patients under-
went preoperative imaging studies (computed tomog-
raphy [CT] or magnetic resonance imaging [MRI]) to
evaluate the location of the renal mass. There was no
evidence of lymph node or distant metastases in any
of the six patients.
All patients were informed of the potential risks
and complications of the surgery and all signed written
informed consent documents. The study was approved
by the institutional review board of our institution.
Patients received preoperative renal angiography to
delineate the vascularity in detail, on the day before
laparoscopic surgery. During renal angiography, we
used fluoroscopic guidance and 100% ethanol to embo-
lize all major vessels supplying the tumor (Figure).
Renal angiography and tumor embolization proce-
dures were performed by a radiologist. On the day 
of surgery, patients were routinely given one dose of 
a broad-spectrum cephalosporin while they were on
call for the operating room. Before the laparoscopic
procedure, we performed cystoscopy with placement
of a 5-Fr ureteral catheter. The purpose of this ureteral
catheter was to inject methylene blue after excising
renal parenchyma, to determine whether the collecting
system had been involved. The patient was then moved
to the modified flank position for the laparoscopic
procedure. A transperitoneal approach was chosen for
all six patients because there was no tumor located 
in the posterior aspect of any kidney. A 10-mm port
for the camera was placed in the umbilicus. Another
three ports were placed under the camera guide, in-
cluding a 10-mm port in the pararectal line, at the
level of the umbilicus, a 10-mm port placed just be-
low the costal margin at the midclavicular line, and 
a 5-mm port that was situated in the middle axillary
line below the costal margin. After incision of the Toldt
line and reflection of the colon, the kidney was mobi-
lized and the renal hilum was identified. The renal
parenchyma was exposed and the tumor was isolated.
A harmonic scalpel was used to score a 1-cm tumor-
free margin outside the boundaries of the tumor. Tumor
excision was then performed slowly using the har-
monic scalpel. Bleeding from the tumor bed was con-
trolled by an argon beam coagulator. The specimen was
removed through one of the ports using the laparo-
scopic sac. Renal bed biopsies were obtained and sent
A B
Figure. (A) Renal tumor enhanced by angiography. (B) Tumor embolized by 100% ethanol.
for frozen section. We injected methylene blue via 
a ureteral catheter and placed sutures if a broken col-
lecting system was identified. The renal parenchymal
surface was extensively fulgurated using the argon
beam coagulator. Finally, the renal surface was covered
with Surgicel, and a drain tube was placed through a
posterior working port site. Additional parenchymal
sutures were not necessary. All procedures were per-
formed without clamping the renal vessels.
RESULTS
Table 1 lists the demographic, surgical and pathologic
data. The laparoscopic procedure was successful in
all six cases. Mean patient age was 57.5 years (range,
29–71 years). Mean tumor size was 2.85 cm (range,
2.0–4.0 cm). Mean estimated blood loss was 176.7 mL
(range, 40–410mL). Only one patient (Patient 2) needed
a blood transfusion intraoperatively due to anemia
(hemoglobin, 9.2 g/dL), which was noted preopera-
tively. The average laparoscopic time was 243.3 minutes
(range, 160–290 minutes).
Intraoperatively acquired frozen sections demon-
strated RCC with a free resection margin in four
patients (Patients 1, 3, 4, 6), and inflammatory tissue
in the other two patients (Patients 2 and 5). However,
the final pathologic report for Patient 5 was changed
to grade 1 RCC with a tiny positive surgical margin.
Nevertheless, we did not perform additional surgical
intervention in this patient after discussion with the
patient and his family. Therefore, final histopathology
confirmed the diagnosis of stage pT1 RCC in five out
of six patients (Patients 1, 3, 4, 5, 6) and an infected
cyst in Patient 2.
The mean time to oral intake was 2 days (range,
1–3 days), and mean hospital stay was 6.5 days (range,
5–10 days). There were no major postoperative com-
plications in any patient. All patients received regular
follow-up by renal echogram, chest X-ray and CT.
Neither residual tumor nor recurrent tumor could be
identified at a mean follow-up of 30 months (range,
25–36 months) postoperatively, including in Patient 5.
DISCUSSION
Because of the widespread use of ultrasonography,
CT and MRI, the number of incidentally detected
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renal masses has increased significantly [8]. Often,
these patients have tumors that are of a small size and
at an early stage. Regarding renal cancer, there have
been many studies suggesting that partial nephrec-
tomy is equivalent to open radical nephrectomy in
terms of long-term cancer-free survival when there 
is unilateral renal involvement, unifocal disease and
a tumor < 4 cm [9,10]. Therefore, this indication for
performing partial nephrectomy is becoming more
widely accepted, even in the setting of a normal 
contralateral kidney [11,12].
Laparoscopic partial nephrectomy was initially
developed in a porcine model in 1993 by McDougall
et al [13]. In the same year, Winfield et al reported 
the first transperitoneal LPN in a human [14]. Sub-
sequently, several clinical series have presented suc-
cessful experiences with LPN [15–17]. During open
surgical procedures, bleeding control and renal hypo-
thermia are efficiently achieved by clamping of the
renal artery and placing ice-slush around the kidney,
but this traditional method is difficult when using
laparoscopic access. Ward determined that the op-
timal temperature for regional renal hypothermia to
achieve renal preservation is 15°C [18]. A warm is-
chemia time of < 30 minutes is the goal; longer times
are associated with either permanent loss of function
or delayed return of function. Several techniques for
renal cooling during laparoscopic partial nephrec-
tomy have been described [19–22]. However, all of
these techniques have clinical limitations. Fortu-
nately, the development of many energy sources, such
as the harmonic scalpel, bipolar cautery, argon-beam
coagulator and Fibrin sealant, make it possible to
perform partial nephrectomy without clamping the
renal vessels [23].
The advantages of renal vascular clamping during
LPN are better visibility of the cutting surface [24],
less blood loss and shorter operative time. On the other
hand, there are benefits to performing LPN without
vascular clamping. First, it can avoid warm ischemic
time and its associated risk of acute tubular necrosis.
Second, it is not necessary to isolate renal vessels in
every case, especially in patients whose renal pedicle
is too hard to explore because of previous inflamma-
tion. Third, the complication rate of renal vessel injury
is reduced.
Despite the application of all kinds of hemostatic
instruments, the average blood loss during laparo-
scopic partial nephrectomy without clamping renal
vessels is still significant (367–708 mL) [4,24,25].
Although the role of embolization in managing RCC
has always been controversial, preoperative embo-
lization has been used to reduce blood loss before
subsequent nephrectomy [7]. In our study, angiog-
raphy was performed preoperatively. This procedure
is able to not only delineate the renal vascularity in
detail, but it can also achieve tumor embolization
before surgery on the following day. The average
blood loss in our patients was 193.3 mL, lower than
that in previous studies [24–26] (Table 2). This benefit
may be a result of combining the use of a harmonic
scalpel, an argon beam coagulator and preoperative
tumor embolization. Although preoperative embo-
lization can reduce blood loss, we must keep in mind
the potential complications of angiography and em-
bolization. Possible complications include puncture
site bleeding, embolus from vessel atheroma, in-
farction and secondary hypertension. However, none
of the above complications were observed in our
patients.
Table 2. Literature on laparoscopic partial nephrectomy without pedicle clamping
n Mean tumor size (cm) Hemostasis instruments Mean blood loss (mL)
Howard et al 6 – Electrocautery blade 525
Argon beam coagulator
Guillonneau et al 12 1.91 Harmonic scalpel 708
Bipolar cautery
Sundaram et al 3 2.53 Tissue link 275
Floating ball
This study 6 2.85 Embolization 176.7
Harmonic scalpel
Argon beam coagulator
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In Patient 5 of this study, the initial report from an
intraoperative frozen section suggested inflammatory
tissue, but the final histopathology report was changed
to grade 1 RCC with a tiny positive surgical margin.
After discussion with the patient and his family, we
did not perform further surgical intervention in this
patient because we had performed tumor emboliza-
tion before the operation and had made extensive ful-
guration of the renal parenchymal surface using an
argon beam coagulator, which can lead to the devel-
opment of a zone of homogeneous coagulation to 
a depth of about 2–3 mm from the surface. This patient
received close follow-up by ultrasound and CT. No
residual tumor could be identified by imaging stud-
ies after a 24-month follow-up. This result might be
due to the contribution of both preoperative tumor
embolization and the use of the argon beam coagula-
tor. The extra 2–3 mm depth of the coagulative zone
developed by the argon beam coagulator, and its as-
sociated inflammatory process around this area, may
confer an additional benefit: the ability to kill any
residual tumor.
The length of hospital stay of inpatients in Taiwan
is considerably longer than that in the US and most
European countries, and this may be due to differ-
ences in health insurance policies. The insurance pre-
mium is very low for Taiwanese citizens covered by
the National Health Insurance, so patients do not want
to be discharged until they think they have completely
recovered.
To our knowledge, we are the first group to com-
bine preoperative tumor embolization and LPN, and
our initial experience is encouraging. However, the
tumors we chose were small and close to the periph-
ery of the kidney, so clamping the renal vessels was
not necessary. Certainly, if a tumor is located nearer
the center of the kidney or if a larger tumor is tar-
geted, clamping the renal vessels before initiating the
parenchymal incision is still suggested. A limitation
of this study is the lack of a control group. We did not
have many patients with small exophytic RCCs in our
institution. A randomized study with a comparison
group (embolization and non-embolization) will be
necessary to confirm these findings.
In conclusion, our initial experience suggests that
preoperative tumor embolization can reduce blood
loss during subsequent LPN, especially during pro-
cedures in which clamping of renal vessels is not
required. Preoperative tumor embolization may also
help to prevent the disastrous effect of incomplete
tumor resection. Long-term follow-up of more cases
is necessary to confirm the efficacy and safety of this
management option.
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